Sort
50,496 grants matching “lung cancer”
EGFR Mutations in Non-Small Cell Lung Cancer
$495,415Bruce E. Johnson · Dana-Farber Cancer Inst · R01 · FY2012 · CA
A cohort study of air pollution, lung cancer, and COPD in Los Angeles County
$495,366Iona C Cheng · Cancer Prevention Instit Of California · R01 · FY2016 · ES
EGFR Mutations in Non-Small Cell Lung Cancer
$495,346Bruce E. Johnson · Dana-Farber Cancer Inst · R01 · FY2015 · CA
EGFR Mutations in Non-Small Cell Lung Cancer
$495,346Bruce E. Johnson · Dana-Farber Cancer Inst · R01 · FY2016 · CA
Machine learning accelerated on-line adaptive replanning
$495,299X. Allen Li · Medical College Of Wisconsin · R01 · FY2021 · CA
Biomarker Development Laboratory
$495,245Leopoldo Nicolas Segal · New York University School Of Medicine · U2C · FY2024 · CA
FLUORESCENT TISH PROBES FOR CANCER REVELANT SEQUENCES
$495,238Princeton University · R33 · FY2003 · CA
THE EFFECT OF TUMOR MICROENVIRONMENT ON METASTASIS
$495,221Maja Hrzenjak Oktay · Albert Einstein College Of Medicine · R01 · FY2022 · CA
THE EFFECT OF TUMOR MICROENVIRONMENT ON METASTASIS
$495,221Maja Hrzenjak Oktay · Albert Einstein College Of Medicine · R01 · FY2023 · CA
Bronchoscopic Steerable Needles for Transparenchymal Access to Lung Nodules
$495,220Ron Alterovitz · Univ Of North Carolina Chapel Hill · R01 · FY2019 · EB
Project 1: Evaluating stem-like T cells and improving efficacy of checkpoint inhibitors in NSCLC
$495,197Rafi Ahmed · Emory University · P50 · FY2020 · CA
Cellular plasticity gives rise to phenotypic equilibrium in small cell lung carcinoma
$495,126Mohamed E. Abazeed · Northwestern University At Chicago · U01 · FY2022 · CA
Lung Screening: Efficacy versus Effectiveness
$495,096Ilana F Gareen · Brown University · R01 · FY2019 · CA
Molecular and biochemical basis of Lymphangioleiomyomatosis
$495,095John Blenis · Weill Medical Coll Of Cornell Univ · R01 · FY2015 · HL
Nutrional Epidemiology of Cancer
$495,028Meir J Stampfer · Harvard School Of Public Health · R25 · FY2007 · CA
Illumina Genome Analyzer II
$495,000George S. Grills · Cornell University · S10 · FY2009 · RR
Leveraging cross-cancer shared heritability to better understand the genetic architecture of cancer
$494,993Sara Lindstroem · University Of Washington · U01 · FY2023 · CA
Clinical trials employing cancer vaccine combination therapies
$494,990James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Cancer Therapy Clinical Trials Using Novel Recombinant Vaccines
$494,990James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Tumor Organoid-Mediated Drug Testing and Clonality Analysis in Peritoneal Surface Disease of Intestinal Origin
$494,928Konstantinos Votanopoulos · Wake Forest University Health Sciences · R01 · FY2022 · CA
Translating Molecular and Clinical Data to Population Lung Cancer Risk Assessment
$494,898Rayjean J. Hung · Baylor College Of Medicine · U19 · FY2017 · CA
The Epidemiology of Molecular Alterations in Mesothelioma
$494,897Karl T Kelsey · Brown University · R01 · FY2009 · CA
Epigenetic miRNA, SNP Signatures, and their Functions in Lung Cancer Outcomes
$494,883Jian Gu · University Of Tx Md Anderson Can Ctr · R01 · FY2018 · CA
Transcriptomic origins of cancer
$494,875Sridhar Hannenhalli · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Epigenetic miRNA, SNP Signatures, and their Functions in Lung Cancer Outcomes
$494,829Xifeng Wu · University Of Tx Md Anderson Can Ctr · R01 · FY2016 · CA